Literature DB >> 8020268

Respiratory function, electrocardiography and quality of life in individuals with muscular dystrophy.

G Ahlström1, L G Gunnarsson, A Kihlgren, A Arvill, P O Sjödén.   

Abstract

All individuals in a Swedish county afflicted with any type of hereditary muscular dystrophy (MD) were identified and 57 (85 percent) of eligible individuals in the age range 16 to 64 were included in the study. Respiratory disturbances were estimated by means of spirometry and analysis of arterial blood gases, and 58 percent yielded abnormal results on at least one of these examinations. Elevated PCO2 was found more commonly than reduced forced vital capacity (FVC) and there was a moderate association between these parameters. Respiratory symptoms, most commonly breathlessness, were encountered in 79 percent. Pathologic ECG recordings were found in 21 individuals (37 percent). Conduction disturbances and affection of the myocard were most frequent in myotonic dystrophy. Quality of life was assessed by means of the Sickness Impact Profile instrument and the Kaasa test. The results showed that quality of life was significantly related to FVC and to the symptom of abnormal fatigue. Respiratory and cardiac parameters showed a greater number of significant correlations with measures of functional ability than with subjective well-being.

Entities:  

Mesh:

Year:  1994        PMID: 8020268     DOI: 10.1378/chest.106.1.173

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

Review 1.  Quality of life in rare genetic conditions: a systematic review of the literature.

Authors:  Julie S Cohen; Barbara B Biesecker
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

2.  Quality of life and impairment in patients with multiple sclerosis.

Authors:  A-K Isaksson; G Ahlström; L-G Gunnarsson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

Review 3.  A systematic review of quality of life in adults with muscle disease.

Authors:  Christopher D Graham; Michael R Rose; Elizabeth A Grunfeld; Simon D Kyle; John Weinman
Journal:  J Neurol       Date:  2011-05-20       Impact factor: 4.849

4.  Respiratory function and therapeutic expectations in DMD: families experience and perspective.

Authors:  Claudia Brogna; Simona Lucibello; Giorgia Coratti; Gianluca Vita; Valeria A Sansone; Sonia Messina; Emilio Albamonte; Francesca Salmin; Gloria Ferrantini; Elisa Pede; Chiara Consulo; Lavinia Fanelli; Nicola Forcina; Giulia Norcia; Marika Pane; Eugenio Mercuri
Journal:  Acta Myol       Date:  2020-09-01

5.  Validation of the individualised neuromuscular quality of life for the USA with comparison of the impact of muscle disease on those living in USA versus UK.

Authors:  Reza Sadjadi; Kelly A Vincent; Alison J Carr; Jessica Walburn; Victoria L Brooks; Shree Pandya; John T Kissel; Carlayne E Jackson; Michael R Rose
Journal:  Health Qual Life Outcomes       Date:  2011-12-16       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.